Market Overview

According to fortune business insights, the global cardiac pacemaker market share was valued at USD 5.06 billion in 2025. The market is projected to grow from USD 5.29 billion in 2026 to USD 7.58 billion by 2034, exhibiting a compound annual growth rate (CAGR) of 4.59% during the forecast period. Europe dominated the global cardiac pacemaker market with a share of 37.07% in 2025.

Cardiac pacemakers are implantable electronic medical devices designed to regulate and monitor heartbeats by delivering small electrical impulses. These devices are primarily used to treat abnormal heart rhythms, including arrhythmia and bradycardia. Increasing cardiovascular disease prevalence, an aging population, growing awareness regarding heart health, and advancements in cardiac rhythm management technologies are supporting market expansion.

Major Players Profiled

Market Segmentation

By Product:

By End User:

Dual-chamber pacemakers dominated the product segment, accounting for approximately 71.2% of the global market. Their widespread adoption is attributed to their ability to coordinate electrical stimulation between the heart's upper and lower chambers, supporting more synchronized heart functioning.